1
Syed M Waheed
Bhatnagar Rakesh, Waheed Syed Mohsin, Chauhan Vibha: High level constitutive production of anthrax protective antigen. Bhatnagar Rakesh, Waheed Syed Mohsin, Chauhan Vibha, GUPTA Bhartee, May 15, 2003: WO/2003/040179

The present invention relates to a process for preparing anthrax protective antigen protein from E.coli using fed batch culture. This process creates a constitutively expressing system for rapid, efficient, cost-effective and high-level production of anthrax PA from E.coli. The steps of the process ...


2
Jain Rajesh, Jindal Kour Chand, Devarajan Sampath Kumar: Novel buccoadhesive compositions and process of preparation thereof. Panacea Biotec, Jain Rajesh, Jindal Kour Chand, Devarajan Sampath Kumar, GUPTA Bhartee, August 30, 2007: WO/2007/096906 (15 worldwide citation)

Novel buccoadhesive compositions comprising at least one bioactive agent(s), at least one bioadhesive polymer(s), at least one water soluble sugar component(s) and at least one binder(s), optionally with other excipients are provided, wherein the said composition has improved cohesiveness, enhanced ...


3
Jain Rajesh, Jindal Kour Chand, Devarajan Sampath Kumar: Injectable depot composition and its process of preparation. Panacea Biotec, Jain Rajesh, Jindal Kour Chand, Devarajan Sampath Kumar, GUPTA Bhartee, April 10, 2008: WO/2008/041245 (15 worldwide citation)

Novel injectable depot compositions are provided comprising at least one active agent(s) optionally with one or more pharmaceutically acceptable excipient(s) in the form of a multi-component system preferably comprising at least two components which when administered to a subject in need thereof fon ...


4
Jain Rajesh, Jindal Kour Chand, Singh Sukhjeet, Talwar Munish: Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor. Panacea Biotec, Jain Rajesh, Jindal Kour Chand, Singh Sukhjeet, Talwar Munish, GUPTA Bhartee, January 25, 2007: WO/2007/010559 (14 worldwide citation)

Pharmaceutical modified release dosage form comprising at least one cyclooxygenase enzyme inhibitor or its pharmaceutically acceptable salts, esters, prodrugs, solvates, hydrates, or derivatives thereof as active agent, with a pharmaceutically acceptable carrier for controlling the release of the cy ...


5
Jain Rajesh, Singh Sukhjeet, Devarajan Sampath Kumar: Injectable compositions, processes and uses thereof. Panacea Biotec, Jain Rajesh, Singh Sukhjeet, Devarajan Sampath Kumar, GUPTA Bhartee, May 14, 2009: WO/2009/060473 (13 worldwide citation)

Injectable depot gel or implant compositions comprising at least one active agent(s) selected from a group comprising antipsychotics, aromatase inhibitors, alpha-1 adrenergic blocking agents, acetylcholinesterase inhibitors, and pharmaceutically acceptable salts, derivatives, isomers, polymorphs, so ...


6
Jain Rajesh, Jindal Kour Chand, Singh Sukhjeet, Boldhane Sanjay: Pharmaceutical sustained release compositions and processes thereof. Panacea Biotec, Jain Rajesh, Jindal Kour Chand, Singh Sukhjeet, Boldhane Sanjay, GUPTA Bhartee, January 4, 2007: WO/2007/000779 (12 worldwide citation)

Pharmaceutical sustained release composition comprising at least one active agent(s), or its tautomeric forms, analogues, isomers, polymorphs, solvates, or salts thereof; preferably an antiviral active agent is provided. Also provided is a process of preparation of such composition and method of usi ...


7
Jain Rajesh, Jindal Kour Chand, Singh Sukhjeet, Boldhane Sanjay: Injectable compositions and process for preparation of such compositions. Panacea Biotec, Jain Rajesh, Jindal Kour Chand, Singh Sukhjeet, Boldhane Sanjay, GUPTA Bhartee, November 30, 2006: WO/2006/126214 (9 worldwide citation)

Novel and highly stable injectable pharmaceutical compositions comprising at least one cyclooxygenase-II enzyme (COX-II) inhibitor or non-steroidal anti-inflammatory drug (NSAID) or .COX/LOX inhibitor, or its tautomeric forms, analogues, isomers, polymorphs, solvates, prodrugs or salts thereof as ac ...


8
Jain Rajesh, Jindal Kour Chand, Boldhane Sanjay: Controlled release formulation of coated microparticles. Panacea Biotec, Jain Rajesh, Jindal Kour Chand, Boldhane Sanjay, GUPTA Bhartee, October 16, 2008: WO/2008/122993 (8 worldwide citation)

Controlled release compositions comprising microparticles which comprise a core and at least one coat, wherein the core comprises at least one active agent(s), optionally at least one water soluble polymer(s) and optionally one or more pharmaceutically acceptable excipient(s); and at least one coat ...


9
Jain Rajesh, Jindal Kour Chand, Boldhane Sanjay: Modified release pharmaceutical composition and a process of making the same. Panacea Biotec, Jain Rajesh, Jindal Kour Chand, Boldhane Sanjay, GUPTA Bhartee, July 31, 2008: WO/2008/090569 (6 worldwide citation)

The present invention refers to a modified release pharmaceutical composition comprising an in-situ gelling agent (=0,5 % w/w) and a gellation facilitating agent (e.g. calcium sulfate) in an amount of 2-17,5 % w/w. Additionally, the composition contains a release rate controlling polymer such as an ...


10
Jain Rajesh, Singh Sukhjeet: Modified release pharmaceutical compositions comprising mycophenolate and processes thereof. Panacea Biotec, Jain Rajesh, Singh Sukhjeet, GUPTA Bhartee, September 11, 2009: WO/2009/110005 (6 worldwide citation)

Modified release pharmaceutical compositions comprising mycophenolate as the active agent or its pharmaceutically acceptable salts, esters, polymorphs, isomers, prodrugs, solvates, hydrates, or derivatives thereof, wherein the said composition exhibits a biphasic release profile when subjected to in ...



Click the thumbnails below to visualize the patent trend.